Evidence for a functional cardiac interaction between losartan and angiotensin-(1-7) receptors revealed by orthostatic tilting test in rats
- PMID: 15685215
- PMCID: PMC1576057
- DOI: 10.1038/sj.bjp.0706039
Evidence for a functional cardiac interaction between losartan and angiotensin-(1-7) receptors revealed by orthostatic tilting test in rats
Abstract
1. Studies have shown that the angiotensin II (Ang II) AT1 receptor antagonist, losartan, accentuates the orthostatic hypotensive response in anesthetized rats, and there is evidence indicating that this effect is not exclusively mediated by AT1 receptors. 2. We investigated whether the pronounced orthostatic cardiovascular response observed in losartan-treated rats involves an interference with angiotensin-(1-7) (Ang-(1-7)) receptors. 3. Urethane-anesthetized rats were submitted to orthostatic stress (90 degree head-up tilt for 2 min). Intravenous injection of losartan (1 mg kg(-1), n=9) significantly accentuated the decrease in mean arterial pressure (MAP) induced by head-up tilt (-33+/-6% after losartan vs -15+/-8% control tilt). This effect was accompanied by a significant bradycardia (-8+/-3% after losartan vs -3+/-3% control tilt). Another AT1 antagonist, candesartan, did not potentiate the decrease of MAP and did not change the cardiac response induced by head-up tilt. Strikingly, administration of the Ang-(1-7) antagonist, A-779 (10 nmol kg(-1), n=5), totally reversed the bradycardic effect caused by losartan and this effect was accompanied by a tendency towards attenuation of the hypotensive response caused by losartan. 4. These findings indicate that the marked orthostatic cardiovascular response is specific for losartan, and that it may be due, in part, to an interaction of this antagonist with Ang-(1-7) receptors, probably at the cardiac level.
Figures

Similar articles
-
Cardiovascular reactivity after blockade of angiotensin AT1 receptors in the experimental model of tilting test in conscious rats.Br J Pharmacol. 2008 Mar;153(5):966-71. doi: 10.1038/sj.bjp.0707652. Epub 2008 Jan 14. Br J Pharmacol. 2008. PMID: 18193073 Free PMC article.
-
Intracisternal galanin/angiotensin II interactions in central cardiovascular control.Regul Pept. 2005 Apr 15;127(1-3):133-40. doi: 10.1016/j.regpep.2004.11.003. Regul Pept. 2005. PMID: 15680479
-
Comparative study of TA-606, a novel angiotensin II receptor antagonist, with losartan in terms of species difference and orthostatic hypotension.Jpn J Pharmacol. 1999 Sep;81(1):63-72. doi: 10.1254/jjp.81.63. Jpn J Pharmacol. 1999. PMID: 10580372
-
Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.Am J Hypertens. 2005 Apr;18(4 Pt 1):493-9. doi: 10.1016/j.amjhyper.2004.11.007. Am J Hypertens. 2005. PMID: 15831358
-
The effect of losartan and carvedilol on vasopressor responses to adrenergic agonists and angiotensin II in the systemic circulation of Sprague Dawley rats.Auton Autacoid Pharmacol. 2011 Jan-Apr;31(1-2):13-20. doi: 10.1111/j.1474-8673.2010.00461.x. Epub 2010 Dec 20. Auton Autacoid Pharmacol. 2011. PMID: 21166975
Cited by
-
Cardiovascular reactivity after blockade of angiotensin AT1 receptors in the experimental model of tilting test in conscious rats.Br J Pharmacol. 2008 Mar;153(5):966-71. doi: 10.1038/sj.bjp.0707652. Epub 2008 Jan 14. Br J Pharmacol. 2008. PMID: 18193073 Free PMC article.
-
Angiotensin II during Experimentally Simulated Central Hypovolemia.Front Cardiovasc Med. 2016 Mar 3;3:6. doi: 10.3389/fcvm.2016.00006. eCollection 2016. Front Cardiovasc Med. 2016. PMID: 26973842 Free PMC article. Review.
-
Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function.Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2281-90. doi: 10.1152/ajpheart.00618.2005. Epub 2005 Jul 29. Am J Physiol Heart Circ Physiol. 2005. PMID: 16055515 Free PMC article. Review.
-
Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha1-adrenoceptor function.Psychopharmacology (Berl). 2008 Jul;199(1):15-27. doi: 10.1007/s00213-007-1064-9. Epub 2008 Jun 10. Psychopharmacology (Berl). 2008. PMID: 18542932
References
-
- AVERILL D.B., ISHIYAMA Y., CHAPPELL M.C., FERRARIO C.M. Cardiac angiotensin-(1–7) in ischemic cardiomyopathy. Circulation. 2003;108:2141–2146. - PubMed
-
- BRAGA A.N.G., SILVA LEMOS M., DA SILVA J.R., FONTES W.R.P., SANTOS R.A.S. Effects of angiotensins on day-night fluctuations and stress-induced changes in blood pressure. Am. J. Physiol. Reg. Int. Comp. Physiol. 2002;282:R1663–R1671. - PubMed
-
- BROSNIHAN K.B., LI P., FERRARIO C.M. Angiotensin-(1–7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996;27:523–528. - PubMed
-
- CHANSEL D., BIZET T., VANDERMEERSCH S., PHAM P., LEVY B., ARDAILLOU R. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells. Am. J. Physiol. 1994;266:F384–F393. - PubMed
-
- COLLISTER J.P., HENDEL M.D. The role of Ang-(1–7) in mediating the chronic hypotensive effects of losartan in normal rats. J. Renin Angiotensin Aldosterone Syst. 2003;4:176–179. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous